Article Text
Abstract
Doctors’ survival predictions for terminally ill patients have been shown to be inaccurate and there has been an argument for less guesswork and more use of carefully constructed statistical indices. As statisticians, the authors are less confident in the predictive value of statistical models and indices for individual survival times. This paper discusses and illustrates a variety of measures which can be used to summarise predictive information available from a statistical model. The authors argue that models and statistical indices can be useful at the group or population level, but that human survival is so uncertain that even the best statistical analysis cannot provide single-number predictions of real use for individual patients.
- AS, actual survival
- CPS, clinical prediction of survival
- PI, prognostic index
- prognostic index
- category prediction
- survival analysis
- expected survival
Statistics from Altmetric.com
Footnotes
-
Competing interests: the authors have no conflicts of interest to declare.
Read the full text or download the PDF:
Other content recommended for you
- Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience
- Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
- Association of Genetic Polymorphisms in the Paraoxonase 1 Gene With the Risk and Prognosis of Non–Small Cell Lung Cancer in Chinese Han Population
- A systematic review of physicians' survival predictions in terminally ill cancer patients
- Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar
- Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer
- Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancer
- Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study
- A clinical risk score to predict in-hospital mortality in critically ill patients with COVID-19: a retrospective cohort study
- A retrospective review of the palliative surgical management of malignant pleural effusions